Skip to content
Disclosery

ORBIMED ADVISORS LLC: LLY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on LLY, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 257,900 LLY shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 257,900 shares
    Change vs previous 13F +21,100 shares

    5.86% of the 13F portfolio, value $309,332,997.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 236,800 shares
    Change vs previous 13F -64,400 shares

    4.75% of the 13F portfolio, value $217,801,536.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 301,200 shares
    Change vs previous 13F 0 shares

    6.62% of the 13F portfolio, value $323,693,616.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 301,200 shares
    Change vs previous 13F -36,400 shares

    5.51% of the 13F portfolio, value $229,815,600.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 337,600 shares
    Change vs previous 13F 0 shares

    6.62% of the 13F portfolio, value $263,169,328.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 337,600 shares
    Change vs previous 13F 0 shares

    6.7% of the 13F portfolio, value $278,827,216.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 337,600 shares
    Change vs previous 13F 0 shares

    5.41% of the 13F portfolio, value $260,627,200.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 337,600 shares
    Change vs previous 13F not available

    5.47% of the 13F portfolio, value $299,093,344.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).